Showing 1-1 of 1 grant
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Ambrisentan and Sotagliflozin for Prevention of renal Injury; a Randomized Evaluation (ASPIRE)ASPIRE | University Medical Center Groningen | Hiddo Lambers Heerspink | Improving Lives | 01-October-2023 to 30-September-2026 | $1.183.690,64 |